Johnson & Johnson (NYSE: JNJ) is one of the world's most recognized healthcare brands. Ironically, the consumer products like Band-Aids and Tylenol that consumers know it for are technically no longer part of the company after their spinoff as Kenvue.

Today, Johnson & Johnson is a two-headed monster focused on pharmaceutical and medical device innovations. The stock drifted for much of the past year despite the company's strong operating results.

It's unclear how long this will last, making the company a rare bargain in a market operating at all-time highs.

Continue reading

Source Fool.com